During a study oflissencephaly in England and Wales, 23 children were identified with this diagnosis. They were classified as follows: three children had Miller-Dieker syndrome (MDS), 13 had isolated lissencephaly sequence (ILS), two had type II lissencephaly, and five children were reclassified as focal or diffuse cortical dysplasia.
Abstract
During a study oflissencephaly in England and Wales, 23 children were identified with this diagnosis. They were classified as follows: three children had Miller-Dieker syndrome (MDS), 13 had isolated lissencephaly sequence (ILS), two had type II lissencephaly, and five children were reclassified as focal or diffuse cortical dysplasia.
Microdeletions of chromosome 17pl3.3, also known as the Miller-Dieker critical region, have been associated with both MDS and ILS. We used the commercially available Oncor probe for fluorescent in situ hybridisation (FISH) studies on 14 patients and a further four were studied elsewhere. Deletions were identified in all three MDS patients and two of the ILS patients. These results are consistent with previously reported data. No deletions were found in those patients with focal or diffuse cortical dysplasia.
In addition, a CA repeat polymorphism which maps to the Miller-Dieker critical region was studied in 12 families and was informative in nine; the results were consistent with the FISH data.
We conclude that FISH is a reliable method to detect deletions in patients with MDS and ILS and also useful to identify chromosome rearrangements in their parents which are not detected by conventional cytogenetic analysis. The PCR assay, if informative, is also reliable and a useful alternative if only DNA is available.
None of the five children with atypical radiological features had a deletion. We therefore suggest that as well as looking for other aetiologies a careful review ofthe diagnosis should be made of the MDS or ILS cases in whom a deletion is not found. (JMed Genet 1995; 32:275-278) Lissencephaly is a heterogeneous neuronal migration disorder characterised by the complete or partial absence of cerebral gyri which gives the surface of the brain a smooth appearance, hence the name lissencephaly, derived from the Greek words "lissos" = smooth and "encephalos" = brain.
Neuropathologically diffuse cortical dysplasia showed a deletion. Both deletions detected with the PCR assay were paternal (table) .
Discussion
Identification of microscopic and submicroscopic deletions within 17p13.3 in most patients with MDS and some with ILS has allowed more precise counselling for affected families and the offer of prenatal diagnosis in some. In keeping with previous studies we found that FISH is a reliable method to detect deletions in patients with MDS and ILS and that the percentage of deletions found in our patients coincided with those previously reported.3 12 The PCR assay we used also produced reliable results when informative, and is a useful alternative when only DNA is available.
In both cases in which a deletion was identified with this method the paternal allele was absent.
However, both maternal and paternal deletions have been reported.3
All our three patients with MDS had deletions and in a series of 25 patients with MDS, Dobyns et al3 and Ledbetter et a?'2 reported deletions in 22 (88%). They concluded that with appropriate methods, deletions would eventually be detectable in all patients with MDS. As subtle balanced parental chromosomal rearrangements3 18 can be the cause of the deletion, FISH studies should be performed on the parental chromosomes when a deletion is detected in the proband.
In our study the remaining 18 patients who did not have MDS had usually remained unclassified under the general diagnosis of lissencephaly. However, identification of those with ILS, where deletions on 17pl 3.3 have been reported, and those with atypical lissencephaly or a non-lissencephalic cortical dysplasia, where a deletion in this area may not be expected, is important for genetic counselling purposes. Only 13 of our remaining 18 patients fulfilled both the current clinical and radiological criteria on the neuroimaging available for the diagnosis of ILS. Of these 11 had FISH studies and two (18%) had a deletion. This result compares with deletions found in six out of 44 patients (13 6%) discussed by Dobyns et a?4 in a review of the causal heterogeneity in ILS. Recurrence risks in cases of de novo deletions are likely to be low. Other causes of ILS include intrauterine infection, possibly intrauterine hypoperfusion, some cases of autosomal recessive inheritance and otherloci.4 There were no recurrences in our study and Dobyns et a?4 suggested an empirical risk of 7%, when known causes are excluded. This figure is likely to be refined as further rearrangements become detectable in non-deleted cases of ILS.
Five of the 21 childen included in this study did not fit the diagnosis of either MDS or ILS. On radiological assessment primarily on the basis of cranial CT scans, they appeared to fall into the group of non-lissencephalic cortical dysplasias (NLCD) recently reviewed by Barkovic and Kjos.'7 Three ofthem met the clinical criteria of ILS and clinical similarities between ILS and NLCD have been described.'7 The other two had unrelated dysmorphic features. None of these five children had a deletion on 17pi3.3 using FISH or PCR or both. Recurrence risks in patients with focal or diffuse cortical dysplasias are undefined; there were none in our small series with a total of 10 sibs.
We conclude that a clinical and radiological diagnosis of MDS or ILS should be attempted in each patient with lissencephaly, and in those who do not show the deletions other aetiologies should be considered and the diagnosis reviewed. Neuroimaging would be very important in such a review and where not previously undertaken an MRI scan should be recommended, as the extent of the cortical changes are more readily assessed, as are any concomitant white matter changes, commonly associated grey matter heterotopias, the presence of polymicrogyria, and callosal dysgenesis, which can provide further clues as to the aetiology.
